Published in Drug Week, October 1st, 2004
The register provides summary results of GSK-sponsored trials of GSK-marketed medicines. It also notes references to related publications that have appeared in the medical literature.
"The register supplements our efforts to ease access to clinical-trial data for everyone interested in medical research and patient care," said Dr. Tadataka Yamada, chairman, research & development, GSK. "It is important to emphasize, however, that prescribing information approved by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.